Prognostic value of soluble tumor necrosis factor receptors 1 and 2 in multiple sclerosis patients treated with interferon beta-1b.

Laske, C; Oschmann, P; Tofighi, J; Kühne, B S; Diehl, H; Bregenzer, T; Kraus, J; Chatzimanolis, N; Bauer, R; Traupe, H; Kaps, M

Laske, C; Oschmann, P; Tofighi, J; Kühne, B S; Diehl, H; Bregenzer, T; Kraus, J; Chatzimanolis, N; Bauer, R; Traupe, H; Kaps, M.

Affiliation

Laske C; Department of Neurology, Justus Liebig University, Giessen, Germany.

Eur Neurol ; 46(4): 210-4, 2001.

Article in En | MEDLINE | ID: mdl-11721129

Subject(s)

Antigens, CD/drug effects; Interferon-beta/therapeutic use; Multiple Sclerosis/drug therapy; Receptors, Tumor Necrosis Factor/drug effects; Adult; Antigens, CD/blood; Brain/drug effects; Brain/pathology; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta/adverse effects; Magnetic Resonance Imaging; Male; Multiple Sclerosis/blood; Multiple Sclerosis/diagnosis; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor/blood; Receptors, Tumor Necrosis Factor, Type II

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antigens, CD / Interferon-beta / Receptors, Tumor Necrosis Factor / Multiple Sclerosis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Eur Neurol Year: 2001 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links